Fund Holdings — Kynam Capital Management, LP

Total Portfolio Value:
$955.19M
Total Bought:
$191.00M
Total Sold:
$34.57M
Net Transaction:
+$156.43M
Notable People:
Kynam Capital Management Gp,
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Natera, Inc.(NTRA)2,000,0002,014,408+14,408$182.92M$218.14M22.84%+$35.22M
Celldex Therapeutics, Inc.(CLDX)2,900,0003,388,967+488,967$121.71M$125.43M13.13%+$3.71M
Syndax Pharmaceuticals, Inc.(SNDX)5,660,0005,722,057+62,057$134.71M$117.47M12.30%-$17.23M
Dynavax Technologies Corp4,239,7807,082,562+2,842,782$52.62M$79.54M8.33%+$26.92M
Cogent Biosciences, Inc.(COGT)8,500,0009,260,385+760,385$57.12M$78.07M8.17%+$20.95M
Vaxcyte, Inc.(PCVX)745,000753,240+8,240$50.89M$56.88M5.95%+$5.99M
Vera Therapeutics, Inc.CL A(VERA)1,526,7871,543,669+16,882$65.84M$55.85M5.85%-$9.99M
BioCryst Pharmaceuticals, Inc.(BCRX)6,527,4918,826,710+2,299,219$33.16M$54.55M5.71%+$21.39M
Protagonist Therapeutics Inc1,144,242800,000-344,242$33.10M$27.72M2.90%-$5.38M
2seventy Bio Inc5,953,8255,953,8250$31.85M$22.92M2.40%-$8.93M
Viridian Therapeutics, Inc.(VRDN)133,8771,750,000+1,616,123$2.34M$22.77M2.38%+$20.42M
Wave Life Sciences, Inc.SHS(WVE)3,932,0823,975,521+43,439$24.26M$19.84M2.08%-$4.42M
Travere Therapeutics, Inc.(TVTX)2,000,0002,021,659+21,659$15.42M$16.62M1.74%+$1.20M
Liquidia Corporation(LQDA)2,248,324916,574-1,331,750$33.16M$11.00M1.15%-$22.16M
Ironwood Pharmaceuticals, Inc.CL A(IRWD)1,625,0001,641,891+16,891$14.15M$10.71M1.12%-$3.45M
Tyra Biosciences, Inc.(TYRA)515,190566,715+51,525$8.45M$9.06M0.95%+$612.7K
Amarin Corp PlcADR12,022,95712,155,830+132,873$10.71M$8.36M0.88%-$2.35M
Burning Rock Biotech LimitedADS(BNR)0974,668+974,668$0$6.28M0.66%+$6.28M
Sutro Biopharma, Inc.(STRO)2,001,7272,023,683+21,956$11.31M$5.93M0.62%-$5.38M
Acelyrin Inc396,379831,310+434,931$2.68M$3.67M0.38%+$990.5K
Caribou Biosciences, Inc.(CRBU)1,068,5271,646,702+578,175$5.49M$2.70M0.28%-$2.79M
CG Oncology, Inc.(CGON)053,911+53,911$0$1.70M0.18%+$1.70M
Burning Rock Biotech LimitedADS(BNR)9,640,9140-9,640,914$7.02M$0—-$7.02M
Page 1 of 1
Kynam Capital Management, LP — 13F Holdings — Q2 2024 | TickerTrail